Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Carlos A Villegas-Valverde"'
Publikováno v:
Revista Cubana de Hematología, Inmunología y Hemoterapia, Vol 27, Iss 2, Pp 212-223 (2011)
El aumento de la supervivencia de los pacientes con inmunodeficiencia primaria (IDP) ha incrementado el riesgo de desarrollar cáncer, que en la actualidad oscila entre el 4 y el 25 %. Se exponen las IDP que se asocian con una alta incidencia de neop
Externí odkaz:
https://doaj.org/article/872363d9ae1146c498be6502a77b52ea
Autor:
Francisco Sotomayor Lugo, Yaíma Zúñiga Rosales, Oliver Pérez Martín, Evelyn Hernández Reyes, Evelyn M. Antiguas Valdés, Hermes Fundora Hernández, Katia Rodríguez Guitiérrez, Yaima Matas González, Imilla Casado Hernández, Carlos Agustín Villegas Valverde, Bárbara Torres Rives, Lázara Minerva Tam Rey, Ihosvany González Díaz, Yaquima Hernández Rego, Ana María Simón Pita, Consuelo Macías Abraham, Beatriz Marcheco Teruel
Publikováno v:
Egyptian Pediatric Association Gazette, Vol 72, Iss 1, Pp 1-11 (2024)
Abstract Background Recurrent infections in childhood are the main cause of remission to the immunology service. T lymphocytes generated in the thymus are essential for fighting infection, making the thymus area an important predictor of the immune s
Externí odkaz:
https://doaj.org/article/e425f6d77c0e41e39e1664b7aad3648d
Autor:
Yendry Ventura-Carmenate, Fatima Mohammed Alkaabi, Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Yasmine Maher Ahmed, Pierdanilo Sanna, Ayesha Abdulla Almarzooqi, Abeer Abdelrazik, Gina Marcela Torres-Zambrano, Maura Wade-Mateo, David Quesada-Saliba, Loubna Abdel Hadi, Antonio Alfonso Bencomo-Hernandez, Rene Antonio Rivero-Jimenez
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-18 (2021)
Abstract Background The novel SARS-CoV-2 has caused the coronavirus disease 2019 (COVID-19) pandemic. Currently, with insufficient worldwide vaccination rates, identifying treatment solutions to reduce the impact of the virus is urgently needed. Meth
Externí odkaz:
https://doaj.org/article/36a3275ce2cd49b4b8623bc4859d89b2
Autor:
Yandy Marx, Castillo-Aleman, Antonio Alfonso, Bencomo-Hernandez, Yendry, Ventura-Carmenate, Carlos Agustin, Villegas-Valverde, Rene Antonio, Rivero-Jimenez, Fatema, Mohammed Al-Kaabi
Publikováno v:
Photodermatology, Photoimmunology & Photomedicine. 39:296-300
A 41-year-old man with oral pemphigus vulgaris (PV) presented to our clinic with a history of no response to numerous immunosuppressant agents and was referred for extracorporeal photopheresis (ECP) therapy. Although the patient underwent a high-inte
Autor:
Yandy M Castillo-Aleman, Carlos A Villegas-Valverde, Yendry Ventura-Carmenate, Gisela M Suarez-Formigo, Antonio A Bencomo-Hernandez
Publikováno v:
Cureus.
Autor:
Jolanta Antoniewicz-Papis, Katarzyna Guz, Yannik Busch, Agnieszka Orzińska, Jacek Nowak, Agata Mikołowska, René Antonio Rivero Jiménez, Carlos A Villegas Valverde
Publikováno v:
Vox Sanguinis. 116:5-188
Autor:
Carlos Agustin Villegas-Valverde, Antonio Alfonso Bencomo-Hernandez, Yendry Ventura-Carmenate, Fatima Mohammed Alkaabi
Publikováno v:
Hematology & Transfusion International Journal. 9:21-26
Evaluation of immunoprofile as predictive and prognostic biomarker are essential to follow up patients in Multiple Myeloma after autologous hematopoietic stem cells transplantation (AHSCT). It can be defining the engraftment and predicts complication
Publikováno v:
Revista de la Facultad de Medicina. 63:7-18
Characteristics and Specialization of the Immune Response in COVID-19 Abstract The outbreak of coronavirus pneumonia in Wuhan, China, became a pandemic on March 11, 2020. It has caused almost 4 million confirmed cases worldwide, with more than 270,00
Autor:
Yandy Marx, Castillo Aleman, Carlos Agustin, Villegas Valverde, Yendry, Ventura Carmenate, Loubna, Abdel Hadi, Rene Antonio, Rivero Jimenez, Rachid, Rezgui, Shahd Hani, Alagha, Shadi, Shamat, Antonio Alfonso, Bencomo Hernandez
Publikováno v:
Am J Stem Cells
Background and objectives: Drug delivery by nebulization has become a crucial strategy for treating different respiratory and lung diseases. Emerging evidence implicates stem cell therapy as a promising tool in treating such conditions, not only by a
Publikováno v:
MEDICC Review. 23
INTRODUCTION: Advanced age and chronic disease comorbidities are indicators of poor prognosis in COVID-19 clinical progression. Fatal outcomes in patients with these characteristics are due to a dysfunctional immune response. Understanding COVID-19's